About Embody
Embody is a company based in Norfolk (United States) founded in 2014 by Michael Francis was acquired by Zimmer Biomet in January 2023.. Embody has raised $41.4 million across 14 funding rounds from investors including HHS, DARPA and Zimmer Biomet. The company has 25 employees as of December 31, 2021. Embody operates in a competitive market with competitors including Miach Orthopaedics, Collplant, Nanochon, GeniPhys and Nurami Medical, among others.
- Headquarter Norfolk, United States
- Employees 25 as on 31 Dec, 2021
- Founders Michael Francis
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Embody, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$41.4 M (USD)
in 14 rounds
-
Latest Funding Round
$10.4 M (USD), Series C
Sep 20, 2022
-
Investors
HHS
& 8 more
-
Employee Count
25
as on Dec 31, 2021
-
Acquired by
Zimmer Biomet
(Jan 05, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Embody
Embody has successfully raised a total of $41.4M across 14 strategic funding rounds. The most recent funding activity was a Series C round of $10.4 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Series C — $10.4M
-
First Round
First Round
(04 Jan 2017)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2022 | Amount | Series C - Embody | Valuation | cultivate(MD) |
|
| Aug, 2021 | Amount | Debt – Conventional - Embody | Valuation |
investors |
|
| Jul, 2021 | Amount | Series B - Embody | Valuation | Horizon |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Embody
Embody has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, DARPA and Zimmer Biomet. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding for medical device companies is provided.
|
Founded Year | Domain | Location | |
|
Structured debt is provided to life sciences and technology firms.
|
Founded Year | Domain | Location | |
|
Early-stage VC firm funding companies in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Embody
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Embody
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Embody Comparisons
Competitors of Embody
Embody operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Miach Orthopaedics, Collplant, Nanochon, GeniPhys and Nurami Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Bio-engineered surgical implants for connective tissue repair are developed.
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
3D-printed implants are developed for treating joint injuries.
|
|
| domain | founded_year | HQ Location |
Collagen polymers are developed for tissue regeneration applications.
|
|
| domain | founded_year | HQ Location |
Nanofiber and sealant technology for soft tissue repair is developed.
|
|
| domain | founded_year | HQ Location |
A rotator cuff repair system is developed for disease treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Embody
Frequently Asked Questions about Embody
When was Embody founded?
Embody was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Where is Embody located?
Embody is headquartered in Norfolk, United States. It is registered at Norfolk, Virginia, United States.
Is Embody a funded company?
Embody is a funded company, having raised a total of $41.4M across 14 funding rounds to date. The company's 1st funding round was a Series B of $11.5M, raised on Jan 04, 2017.
How many employees does Embody have?
As of Dec 31, 2021, the latest employee count at Embody is 25.
What does Embody do?
Founded in 2014 and based in Norfolk, United States, collagen-based regenerative matrices for soft tissue repair are developed by the company. Manufacturing platforms incorporating electrospinning and microfluidics are utilized in operations. Applications include drug delivery and wound healing, with products such as the Tapestry biointegrative Implant, Microbraid collagen suture, and Microbrace offered in the regenerative medicine sector.
Who are the top competitors of Embody?
Embody's top competitors include Miach Orthopaedics, Collplant and Jellatech.
Who are Embody's investors?
Embody has 9 investors. Key investors include HHS, DARPA, Zimmer Biomet, Horizon Tech Finance, and cultivate(MD).
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.